Skip to content

Boston Scientific BSX Retained Earnings

Retained Earnings at other companies

Abbott logo
AbbottABT
$49.79B+2.7%
TFX
TeleflexTFX
$3.15B-23.5%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$171.67B+3.8%
Stryker logo
StrykerSYK
$20.88B+10.7%
Haemonetics logo
HaemoneticsHAE
$279.34M-20.7%
CONMED logo
CONMEDCNMD
$625.67M+8.7%

Other financials

Income statement

See full
Revenue$5.4B+7.5%
Gross profit$3.8B+12.4%
Operating income$1.2B+43.8%
Net income$907.0M+14.1%
EPS (diluted)$0.61+15.1%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$68.43B-56.7%
P/E18.6×-44.6×
P/S3.3×-5.3×

Profitability

See full
Gross margin69.9%+1.7pp
Operating margin19.8%+2.8pp
Net margin17.5%+4.0pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's retained earnings?
Boston Scientific (BSX) reported retained earnings of $6.91B in Q1 2026.
How has Boston Scientific's retained earnings changed year-over-year?
Boston Scientific's retained earnings increased by 106.5% year-over-year, from $3.35B to $6.91B.
What is the long-term trend for Boston Scientific's retained earnings?
Over 5 years (2020 to 2025), Boston Scientific's retained earnings has grown at a 18.6% compound annual growth rate (CAGR), from -$2.38B to $5.57B.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.